Cymbiotika
Facts-only compliance record. Every entry is source-backed and dated.
Last reviewed: 2026-04-15
Event Timeline
No IgG disclosure at $2.23/serving — most expensive, least transparent
At $2.23/serving, Cymbiotika is the most expensive colostrum in the category while disclosing the least. Does not disclose IgG percentage, processing method, or bioactive quantification. 1.5g serving = 7.5% of clinical trial dose threshold (20g/day). No third-party certifications.
Second Prop 65 settlement for lead — $15,000 (separate product)
Settlement No. 2023-00939S1928 for lead in Cymbiotika products. $15,000 total penalty ($11,250 to OEHHA, $3,750 to ERC). This is a second, separate Prop 65 settlement from the charcoal product case — establishing lead contamination as a recurring issue across the product line.
Prop 65 settlement for Bio-Charged Activated Charcoal
Prop 65 settlement (Case No. 22CV023029) for Bio-Charged Activated Charcoal product. Required annual testing for 4 consecutive years. Violations occurred "every day since at least May 26, 2019." Supplemental 60-day notice (2025-02591) filed June 2025, suggesting ongoing exposure.